Registered entities
Numab Therapeutics Ag
Reg. No. 1288372Switzerland
Social engagement
Social engagement: 8.7K social following, 5 posts in the last 12 months — below the industry typical range.
Investor mix
14 investors on record; lead investors include Mitsubishi UFJ Capital, Eisai Innovation, Sansheng Guojian Pharmaceutical, Novo Holdings.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 36% |
| Private equity | 3 | 21% |
| Accelerator & incubator | 1 | 7% |
| Other / undisclosed | 5 | 36% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
20 Nov 2025 · Formulation & Analytics Intern · Horgen, Zürich
Based on job postings tracked across public sources.
Recent activity
13 Nov 2025
Partnership
Kaken Pharmaceutical Co., Ltd.
25 Sep 2025
Milestone
regulatory
9 Sep 2025
Leadership hire
Chief Executive Officer